Brief: Merck Announces Expiration Of Hart-Scott-Rodino Act Waiting Period To Acquire Terns Pharmaceuticals
24/04/2026 12:17
April 24 (Reuters) - Merck & Co Inc MRK.N: MERCK ANNOUNCES EXPIRATION OF HART-SCOTT-RODINO ACT WAITING PERIOD TO ACQUIRE TERNS PHARMACEUTICALS, INC. MERCK & CO INC - ANNOUNCES HART-SCOTT-RODINO WAITING PERIOD EXPIRED FOR TERNS ACQUISITION ON APRIL 23, 2026 MERCK & CO INC - ON APRIL 7 COMMENCED CASH TENDER OFFER FOR TERNS AT $53.00 PER SHARE (ADDS DROPPED WORDS 'ON APRIL 7')
Recent news on Terns Pharmaceuticals
See all newsNASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. RESEARCH ROUNDUP-East West Bancorp, Reliance, S&P Global
Brief: Merck Announces Expiration Of Hart-Scott-Rodino Act Waiting Period To Acquire Terns Pharmaceuticals
Brief: Merck Begins Tender Offer To Acquire Terns Pharmaceuticals, Inc.